• 

  Evidence for the Need to Evaluate More Than One Source of Extracellular Vesicles, Rather Than Single or Pooled Samples Only, When Comparing Extracellular Vesicles Separation Methods 

  O'Driscoll, Lorraine (2021)

  To study and exploit extracellular vesicles (EVs) for clinical benefit as biomarkers, therapeutics, or drug delivery vehicles in diseases such as cancer, typically we need to separate them from the biofluid into which they ...
• 

  Is it time for greater patient involvement to enhance transitional medication safety? 

  Grimes, Tamasine (2021)
• 

  Design and development of a hydrogel formulation with nanoparticles for the treatment of glioblastoma multiforme 

  Cardoso Dos Santos, Luiza Erthal (Trinity College Dublin. School of Pharmacy & Pharma. Sciences. Discipline of Pharmacy, 2021)

  Glioblastoma multiforme (GBM) is the most aggressive form of brain tumours. GBM treatment is challenging because tumours are highly invasive and it is difficult to achieve effective therapeutic doses of drugs into the ...
• 

  The relationship between antiepileptic drug load and challenging behaviors in older adults with intellectual disability and epilepsy 

  Henman, Martin; O'Dwyer, Maire; Mc Carron, Mary; Monaghan, Rosemary (2021)

  Antiepileptic drugs (AEDs) may affect mood and behavior in people with epilepsy and intellectual disability. A high AED load, derived from AED polytherapy and/or high doses of AEDs, has been suggested to be a risk factor ...
• 

  Pharmacists involvement in COVID-19 vaccination across Europe: A situational analysis of current practice and policy 

  Henman, Martin; Cadogan, Cathal (2021)

  One year since the emergence of the COVID-19 pandemic, rapid response measures have been implemented internationally to mitigate the spread of the virus. Following rapid and successful pre-clinical and human trials, several ...

View more